申请人:Sankyo Company, Limited
公开号:EP1632228A1
公开(公告)日:2006-03-08
A medicinal composition comprising a triazole compound having the general formula (I):
(wherein Ar1 is a phenyl group which may be substituted; Ar2 is a phenyl which may be substituted; R0 is a hydrogen atom; R1 is a lower alkyl group; R2, R3, R4 and R5 are the same or different and each is a hydrogen atom or a lower alkyl group; p is 0 or 1; q, r and s are each 0, 1 or 2; and A is 1,3-dioxane), or a pharmaceutically acceptable ester thereof or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable basic substance.
一种药物组合物,包含通式为(I)的三唑化合物:
(其中 Ar1 是可被取代的苯基;Ar2 是可被取代的苯基;R0 是氢原子;R1 是低级烷基;R2、R3、R4 和 R5 相同或不同,且各自是氢原子或低级烷基;p 是 0 或 1;q、r 和 s 各自是 0、1 或 2;以及 A 是 1,3-二恶烷),或其药学上可接受的酯或其药学上可接受的盐,以及药学上可接受的碱性物质。